Related Experiment Videos
Nonobstructive asymmetrical septal hypertrophy and ostium secundum-type atrial septal defect
P Hernández-Reyes1, N Espinola-Zavaleta, J Vargas-Barrón
1Instituto Nacional de Cardiología Ignacio Chávez, México City, Mexico.
Insights
This study details a rare case of hypertrophic cardiomyopathy and atrial septal defect in a 36-year-old woman. Transesophageal echocardiography confirmed the diagnosis of this uncommon cardiac condition.
Area of Science:
- Cardiology
- Medical Imaging
- Genetics
Background:
- Hypertrophic cardiomyopathy (HCM) is a genetic heart muscle disease.
- Atrial septal defects (ASDs) are common congenital heart anomalies.
- The co-occurrence of HCM and ASD is exceptionally rare.
Observation:
- A 36-year-old woman presented with hypertrophic cardiomyopathy characterized by asymmetric septal hypertrophy.
- The patient also had an ostium secundum-type atrial septal defect causing significant hemodynamic compromise.
- No left ventricular outflow tract obstruction was noted.
Findings:
- Transesophageal echocardiography was instrumental in diagnosing this rare dual cardiac condition.
- This represents the second reported case of this specific association in medical literature.
- It is the first documented instance of this rare combination diagnosed using transesophageal echocardiography.
Implications:
- Highlights the importance of comprehensive echocardiographic evaluation in complex cardiac cases.
- Suggests potential genetic links or shared pathophysiological mechanisms between HCM and ASD.
- Emphasizes the need for further research into the prevalence and management of this rare association.
Abstract:
We report a 36-year-old woman with hypertrophic cardiomyopathy with asymmetric septal hypertrophy without outflow tract obstruction associated with an ostium secundum-type atrial septal defect with significant hemodynamic repercussion. Diagnosis was established with transesophageal echocardiography. This is the second case of this rare association reported in the literature and the first evaluated by transesophageal echocardiography.